quinoxalines has been researched along with D-fructopyranose in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grivas, S; Jägerstad, M; Nyhammar, T; Olsson, K | 2 |
| Skradski, S; White, HS | 1 |
| Dai, W; Deng, W; Follett, PL; Jensen, FE; Massillon, LJ; Rosenberg, PA; Talos, DM; Volpe, JJ | 1 |
| Jensen, FE; Koh, S; Simpson, JN; Tibayan, FD | 1 |
| Nagaraj, RH; Oya-Ito, T; Pfahler, C; Pilch, HA; Puttaiah, S; Sayre, LM; Zhang, Y | 1 |
| Aujla, PK; Fishman, R; Jensen, FE; Rakhade, SN; Sucher, NJ; Zhou, C | 1 |
| Adeli, K; Naples, M; Qiu, W; Su, Q; Tsai, J; Zhang, R | 1 |
| Adeola, M; Loo, M; Patil, T; Poles, A; Raffa, RB; Rawls, SM; Raymondi, N; Thomas, T | 1 |
| Beattie, MS; Bresnahan, JC; Gensel, JC; Tovar, CA | 1 |
10 other study(ies) available for quinoxalines and D-fructopyranose
| Article | Year |
|---|---|
Formation of 4,8-DiMeIQx from the model system fructose, alanine and creatinine. Comparison with the isomeric 5,8-DiMeIQx.
Topics: Alanine; Chromatography, High Pressure Liquid; Creatinine; Fructose; Isomerism; Magnetic Resonance Spectroscopy; Mutagens; Quinoxalines; Structure-Activity Relationship | 1986 |
Formation of a new mutagenic DiMeIQx compound in a model system by heating creatinine, alanine and fructose.
Topics: Alanine; Creatinine; Fructose; Hot Temperature; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mutagens; Quinoxalines; Spectrophotometry, Ultraviolet | 1985 |
Topiramate blocks kainate-evoked cobalt influx into cultured neurons.
Topics: Animals; Anticonvulsants; Calcium; Cations, Divalent; Cells, Cultured; Cerebellum; Cobalt; Excitatory Amino Acid Antagonists; Fructose; Kainic Acid; Magnesium; Mice; Neurons; Quinoxalines; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Topiramate | 2000 |
Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.
Topics: Animals; Calcium; Cell Death; Cell Differentiation; Cell Division; Disease Models, Animal; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fructose; Gestational Age; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Kainic Acid; Leukomalacia, Periventricular; Movement Disorders; Neuroprotective Agents; Oligodendroglia; Quinoxalines; Rats; Receptors, AMPA; Receptors, Glutamate; Topiramate; Treatment Outcome | 2004 |
NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury.
Topics: Animals; Anticonvulsants; Brain; Cell Death; Disease Models, Animal; DNA Fragmentation; Fructose; Hippocampus; Hypoxia, Brain; In Situ Nick-End Labeling; Kainic Acid; Male; Neurons; Neuroprotective Agents; Quinoxalines; Rats; Rats, Long-Evans; Receptors, AMPA; Seizures; Topiramate | 2004 |
Detection of dideoxyosone intermediates of glycation using a monoclonal antibody: characterization of major epitope structures.
Topics: Animals; Antibodies, Monoclonal; Ascorbic Acid; Dipeptides; Epitopes; Fructose; Glucose; Glycation End Products, Advanced; Glycosylation; Hemocyanins; Mice; Quinoxalines; Ribonuclease, Pancreatic; Ribose; Stereoisomerism | 2006 |
Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures.
Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP-Dependent Protein Kinases; Disease Susceptibility; Enzyme Activation; Epilepsy; Excitatory Postsynaptic Potentials; Fructose; Hypoxia; Male; Phosphorylation; Protein Kinase C; Quinoxalines; Rats; Rats, Long-Evans; Receptors, AMPA; Synapses; Topiramate | 2008 |
Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Topics: Administration, Oral; Animals; Apolipoprotein B-100; Cell Line, Tumor; Cell-Free System; Cricetinae; Cysteine Proteinase Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fructose; Gene Expression; Hepatocytes; Humans; I-kappa B Kinase; I-kappa B Proteins; Imidazoles; Inflammation; Leupeptins; Lipid Metabolism; Lipoproteins; Lipoproteins, VLDL; Liver; Male; Mesocricetus; NF-kappa B; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Biosynthesis; Protein Kinase Inhibitors; Quinoxalines; Transfection; Tumor Necrosis Factor-alpha | 2009 |
Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fructose; N-Methylaspartate; Neuroprotective Agents; Planarians; Quinoxalines; Seizures; Topiramate | 2009 |
Topiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injury.
Topics: Analysis of Variance; Animals; Apoptosis; Cervical Vertebrae; Excitatory Amino Acid Antagonists; Female; Fructose; Grooming; Histological Techniques; Movement; Neuroprotective Agents; Oligodendroglia; Quinoxalines; Rats; Rats, Long-Evans; Spinal Cord Injuries; Topiramate | 2012 |